AAAAAA
Results: 1-25/33
Authors:
Bagg, W
Whalley, GA
Gamble, G
Drury, PL
Sharpe, N
Braatvedt, GD
Citation: W. Bagg et al., Effects of improved glycaemic control on endothelial function in patients with type 2 diabetes, INTERN M J, 31(6), 2001, pp. 322-328
Authors:
Tillmann, HC
Sharpe, N
Sponer, G
Wehling, M
Citation: Hc. Tillmann et al., Does intention-to-treat analysis answer all questions in long-term mortality trials? Considerations on the basis of the ANZ trial, INT J CL PH, 39(5), 2001, pp. 205-212
Authors:
Richards, AM
Doughty, R
Nicholls, MG
MacMahon, S
Sharpe, N
Murphy, J
Espiner, EA
Frampton, C
Yandle, TG
Citation: Am. Richards et al., Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin - Prognostic utility and prediction of benefit from carvedilol in chronic ischemicleft ventricular dysfunction, J AM COL C, 37(7), 2001, pp. 1781-1787
Authors:
Whalley, GA
Bagg, W
Doughty, RN
Gamble, G
Braatvedt, G
Sharpe, N
Citation: Ga. Whalley et al., Pseudonormal diastolic filling unmasked with glyceryl trinitrate in patients with type 2 diabetes with poor metabolic control, DIABET CARE, 24(7), 2001, pp. 1307-1308
Authors:
Hunter, AGW
Sharpe, N
Mullen, M
Meschino, WS
Citation: Agw. Hunter et al., Ethical, legal, and practical concerns about recontacting patients to inform them of new information: The case in medical genetics, AM J MED G, 103(4), 2001, pp. 265-276
Authors:
Agewall, S
Doughty, RN
Bagg, W
Whalley, GA
Braatvedt, G
Sharpe, N
Citation: S. Agewall et al., Comparison of ultrasound assessment of flow-mediated dilatation in the radial and brachial artery with upper and forearm cuff positions, CLIN PHYSL, 21(1), 2001, pp. 9-14
Authors:
Dargie, HJ
Sharpe, N
Citation: Hj. Dargie et N. Sharpe, Benefit of beta-blockers after myocardial infarction - Reply, LANCET, 358(9291), 2001, pp. 1457-1458
Authors:
Dargie, HJ
Colucci, Y
Ford, I
Sendon, JLL
Remme, W
Sharpe, N
Blank, A
Holcslaw, TL
Citation: Hj. Dargie et al., Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial, LANCET, 357(9266), 2001, pp. 1385-1390
Authors:
Reid, IR
Hague, W
Emberson, J
Baker, J
Tonkin, A
Hunt, D
MacMahon, S
Sharpe, N
Citation: Ir. Reid et al., Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial, LANCET, 357(9255), 2001, pp. 509-512
Authors:
Ramm, C
Robinson, S
Sharpe, N
Citation: C. Ramm et al., Factors determining non-attendance at a cardiac rehabilitation programme following myocardial infarction, NZ MED J, 114(1132), 2001, pp. 227-229
Authors:
Sharpe, N
Citation: N. Sharpe, Heart failure management: 25 years of progress, NZ MED J, 114(1125), 2001, pp. 23-24
Authors:
Devereux, RB
Palmieri, V
Sharpe, N
De Quattro, V
Bella, JN
de Simone, G
Walker, JF
Hahn, RT
Dahlof, B
Citation: Rb. Devereux et al., Effects of once-daily angiotensin-converting enzyme inhibition and calciumchannel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension - The Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PRESERVE) trial, CIRCULATION, 104(11), 2001, pp. 1248-1254
Authors:
Sharpe, N
Citation: N. Sharpe, Correlations of left ventricular hypertrophy with cardiovascular mortality, INT J CL PR, 2000, pp. 16-22
Authors:
Weinman, J
Petrie, KJ
Sharpe, N
Walker, S
Citation: J. Weinman et al., Causal attributions in patients and spouses following first-time myocardial infarction and subsequent lifestyle changes, BR J H PSYC, 5, 2000, pp. 263-273
Authors:
Doughty, RN
Whalley, GA
Gamble, G
MacMahon, S
Sharpe, N
Citation: Rn. Doughty et al., Effects of carvedilol on left ventricular regional wall motion in patientswith heart failure caused by ischemic heart disease, J CARD FAIL, 6(1), 2000, pp. 11-18
Authors:
Oxenham, H
Sharpe, N
Citation: H. Oxenham et N. Sharpe, Angotensin-converting enzyme inhibitor treatment after myocardial infarction - A selective approach for maximum benefit, J AM COL C, 36(7), 2000, pp. 2054-2055
Authors:
MacMahon, S
Sharpe, N
Gamble, G
Clague, A
Ni Mhurchu, C
Clark, T
Hart, H
Scott, J
White, H
Citation: S. Macmahon et al., Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease, J AM COL C, 36(2), 2000, pp. 438
Authors:
Cohn, JN
Ferrari, R
Sharpe, N
Citation: Jn. Cohn et al., Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling, J AM COL C, 35(3), 2000, pp. 569-582
Authors:
Oxenham, H
Sharpe, N
Citation: H. Oxenham et N. Sharpe, Prognostic stratification in heart failure: what's the point?, EUR HEART J, 21(22), 2000, pp. 1815-1816
Authors:
Bagg, W
Braatvedt, GD
Sharpe, N
Citation: W. Bagg et al., A complex relationship: glucose, insulin and coronary artery disease, EUR HEART J, 21(1), 2000, pp. 8-9
Authors:
Agewall, S
Wright, S
Doughty, RN
Whalley, GA
Duxbury, M
Sharpe, N
Citation: S. Agewall et al., Does a glass of red wine improve endothelial function?, EUR HEART J, 21(1), 2000, pp. 74-78
Authors:
Sutton, MGS
Sharpe, N
Citation: Mgs. Sutton et N. Sharpe, Left ventricular remodeling after myocardial infarction - Pathophysiology and therapy, CIRCULATION, 101(25), 2000, pp. 2981-2988
Authors:
Bagg, W
Whalley, GA
Sathu, A
Gamble, G
Sharpe, N
Braatvedt, GD
Citation: W. Bagg et al., The effect of acute hyperglycaemia on brachial artery flow mediated dilatation in normal volunteers, AUST NZ J M, 30(3), 2000, pp. 344-350
Authors:
Agewall, S
Whalley, GA
Doughty, RN
Sharpe, N
Citation: S. Agewall et al., Handgrip exercise increases postocclusion hyperaemic brachial artery dilatation, HEART, 82(1), 1999, pp. 93-95
Authors:
Doughty, RN
Sharpe, N
Citation: Rn. Doughty et N. Sharpe, Effects of beta-blockers on symptoms and exercise tolerance in patients with heart failure, J CARD RISK, 6(3), 1999, pp. 151-156